Eric Lefkofsky, Founder and CEO of Tempus, shared Tempus AI’s post on LinkedIn, adding:
“For more context around Tempus AI’s Q1 financial results and our advantage in bringing the power and promise of precision medicine to physicians and patients at scale, you can read a joint letter from myself and our CFO, Jim Rogers here.”
Quoting Tempus AI‘s post;
“Today we reported financial results for the quarter ended March 31, 2026.
Read the full report here.”
Other articles featuring Eric Lefkofsky on OncoDaily.